NeoGenomics
Stock Forecast, Prediction & Price Target
NeoGenomics Financial Estimates
NeoGenomics Revenue Estimates
NeoGenomics EBITDA Estimates
NeoGenomics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | ||
Revenue
% change YoY
| $484.32M N/A | $509.72M 5.24% | $591.64M 16.07% | Avg: $719.26M Low: $712.48M High: $725.17M avg. 21.57% | Avg: $792.71M Low: $785.31M High: $798.49M avg. 10.21% | ||
Net Income
% change YoY
| $-8.34M N/A | $-144.25M -1628.16% | $-87.96M 39.01% | Avg: $-47.70M Low: $-60.24M High: $-28.86M avg. 45.76% | Avg: $-35.65M Low: $-55.22M High: $-13.80M avg. 25.25% | ||
EBITDA
% change YoY
| $43.35M N/A | $-83.89M -293.47% | $-17.60M 79.01% | Avg: $12.08M Low: $11.97M High: $12.18M avg. 168.65% | Avg: $13.32M Low: $13.19M High: $13.42M avg. 10.21% | ||
EPS
% change YoY
| -$0.07 N/A | -$1.16 -1566.66% | -$0.7 39.65% | Avg: -$0.36 Low: -$0.48 High: -$0.23 avg. 48.39% | Avg: -$0.26 Low: -$0.44 High: -$0.11 avg. 27.33% | ||
Operating Expenses
% change YoY
| $305.81M N/A | $341.00M 11.50% | $341.25M 0.07% | Avg: $372.07M Low: $368.56M High: $375.13M avg. 9.03% | Avg: $410.06M Low: $406.24M High: $413.05M avg. 10.21% | ||
FAQ
What is NeoGenomics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 35.51% in 2025-2026.
We have gathered data from 9 analysts. Their low estimate is -60.24M, average is -47.70M and high is -28.86M.
What is NeoGenomics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 15.89% in 2025-2026.
We have gathered data from 10 analysts. Their low revenue estimate is $712.48M, average is $719.26M and high is $725.17M.
What is NeoGenomics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 37.86% in 2025-2026.
We have gathered data from 9 analysts. Their low earnings per share estimate is -$0.48, average is -$0.36 and high is $-0.23.
What is the best performing analyst?
In the last twelve months analysts have been covering NeoGenomics stock. The most successful analyst is Mark Massaro.